Douglas G. Cole
Director, AVEO PHARMACEUTICALS, INC.
Companies
- Foghorn Therapeutics Inc.Board member Oct 22, 2020 to now1
- Sana BiotechnologyBoard member Feb 3, 2021 to Jul 15, 20242
- Sigilon Therapeutics, Inc.Board member Dec 3, 2020 to Aug 11, 20233
- Denali Therapeutics Inc.Board member Dec 7, 2017 to Jun 5, 20234
- Quanterix (United States)Board member Dec 6, 2017 to Jan 4, 20195
- Editas MedicineBoard member Feb 2, 2016 to Aug 21, 20176
- Agios PharmaceuticalsBoard member Jul 23, 2013 to Aug 11, 20167
- Tetraphase Pharmaceuticals (United States)Board member Mar 19, 2013 to May 20, 20138
- AVEO PHARMACEUTICALS, INC.Board member Mar 11, 2010 to May 16, 20119
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Denali Therapeutics Inc. DNLI26,564 shares10$484.8K at $18.25Jun 1, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 1, 2023Granted 4,216 shares of Denali Therapeutics Inc.10
- Jun 2, 2022Granted 5,986 shares of Denali Therapeutics Inc.11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARSana Biotechnology, Board member
- 3
- 4
- 5
- 6SEC EDGAREditas Medicine, Board member
- 7SEC EDGARAgios Pharmaceuticals, Board member
- 8
- 9
- 10
- 11SEC EDGARForm 4 filed Jun 6, 2022